Unusual histological variants of cutaneous malignant melanoma with some clinical and possible prognostic correlations

Journal of Cutaneous Pathology

Volumn 32, Issue 9, 2005, Pages 589-603

  Rongioletti, Franco ^a,c   Smoller, Bruce R ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Clinica Dermatologica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN;

AMELANOTIC MELANOMA; CANCER CLASSIFICATION; CLEAR CELL SARCOMA; CYTOLOGY; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MELANOMA; MERKEL CELL; PROGNOSIS; REVIEW; RHABDOID TUMOR; VERRUCOUS CARCINOMA;

HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; PROGNOSIS; SKIN NEOPLASMS;

EID: 26244444677     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2005.00418.x     Document Type: Review

References (101)

1. Barnhill RL. Pathology of Melanocytic Nevi and Malignant Melanoma. Boston: Butterworth-Heinemann, 1995; 195.
2. Weedon D. Lentigines, nevi and melanomas. In: Weedon D. Skin Pathology, 2nd edn. Edinburgh: Churchill Livingstone, 2002; 803.
3. Barnhill RL. Tumors of melanocytes. In: Barnhill RL, Crowson AN. Textbook of Dermatopathology, 2nd edn. New York: McGraw-Hill, 2004; 675.
4. Kiene P, Petres-Dunsche C, Folster-Holst R. Pigmented peduncolated melanoma: a rare variant of nodular melanoma. Br J Dermatol 1995; 133: 300.
5. McGowern VJ, Shaw HM, Milton GW. Prognostic significance of a polypoid configuration in malignant melanoma. Histopathology 1983; 7: 663.
6. Blessing K, Evans AT, al-Nafussi A. Verrucous naevoid and keratotic malignant melanoma: a clinico-pathologic study of 20 cases. Histopathology 1993; 23: 453.
7. Steiner A, Konrad K, Pehamberger H, Wolff K. Verrucous malignant melanoma. 1988; 124: 1534.
8. Hanly AJ, Jorda M, Elgart GW. Cutaneous malignant melanoma associated with extensive pseudoepitheliomatous hyperplasia. J Cutan Pathol 2000; 27: 153.
9. Kuehln-Petzold CH, Berger H, Wiebelt H. Verrucous-keratotic variations of malignant melanoma: a clinicopathologic study. Am J Dermatopathol 1982; 4: 403.
10. Nakhleh RE, Wick MR, Rocamora A, Swanson PE, Denher LP. Morphologic diversity in malignant melanomas. Am J Clin Pathol 1990; 93: 731.
11. Adler MJ, Beckstead J, White CR. Angiomatoid melanoma: a case of metastatic melanoma mimicking a vascular malignancy. Am J Dermatopathol 1997; 19: 606.
12. Baron JA, Monzon F, Galaria N, Murphy GF. Angiomatoid melanoma: a novel pattern of differentiation in invasive periocular desmoplastic malignant melanoma. Hum Pathol 2000; 31: 1520.
13. Zelger BG, Zelger B. Angiomatoid metastatic melanoma. Dermatol Surg 2004; 30: 336.
14. Barnhill RL, Lugassy C. Angiotropic malignant melanoma and extravascular migratory metastasis, description of 36 cases with emphasis on a new mechanism of tumour spread. Pathology 2004; 36: 485.
15. Bowen GM, Chang AE, Lowe L, Hamilton T, Patel R, Johnson TM. Solitary melanoma confined to the dermal and/or subcutaneous tissue: evidence for revisiting the staging classification. Arch Dermatol 2000; 136: 1397.
16. Swetter SM, Ecker PM, Johnson DL, Harvell JD. Primary dermal melanoma: a distinct subtype of melanoma. Arch Dermatol 2004; 140: 99.
17. Anstey A, McKee P, Wilson-Jones E. Desmoplastic malignant melanoma: a clinicopathologic study of 25 cases. Br J Dermatol 1993; 129: 359.
18. Rongioletti F, Gambini C, Semino MT, Rebora A. Desmoplastic and neurotropic subungual melanoma. Ann Dermatol Venereol (French) 1995; 172: 707.
19. Crotty K, McCarthy W, Quinn M, McCarthy S. Alopecia neoplastica caused by desmoplastic melanoma. Australas J Dermatol 2003; 44: 295.
20. Carlson JA, Dickersin GR, Sober AJ, Barnhill RL. Desmopastic neurotropic melanoma: a clinicopathologic analysis of 26 cases. Cancer 1995; 75: 478.
21. Baer SC, Schultz D, Synnestvedt M, Elder DE. Desmoplasia and neurotropism. Prognostic variables in patients with stage I melanoma. Cancer 1995; 76: 2242.
22. Anstey A, Cerio R, Ramnarain N. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases. Am J Dermatopathol 1994; 16: 14.
23. Kanik AB, Yaar M, Bhawan J. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma. J Cutan Pathol 1996; 23: 205.
24. Kucher C, Zhang PJ, Pasha T, et al. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi. Am J Dermatopathol 2004; 26: 452.
25. Longacre TA, Egbert BM, Rouse RV. Desmoplastic and spindle cell malignant melanoma. An immunohistochemical study. Am J Surg Pathol 1996; 20: 1489.
26. Kay PA, Pinheiro AD, Lohse CM, et al. Desmoplastic melanoma of the head and neck: histopathologic and immunohistochemical study of 28 cases. Int J Surg Pathol 2004; 12: 17.
27. From L, Hanna W, Khan HJ, et al. Origin of the desmoplasia in desmoplastic malignant melanoma. Hum Pathol 1983; 14: 1072.
28. Fearns C, Dowdle EB. The desmoplastic response: induction of collagen synthesis by melanoma cells in vitro. Int J Cancer 1992; 50: 621.
29. DiMaio SM, Mckay B, Smith JL, Dickersin GR. Neurosarcomatous transformation in malignant melanoma. An ultrastructural study. Cancer 1982; 50: 2345.
30. Winnepenninckx V, De Vos R, Stas M, van den Oord JJ. New phenotypical and ultrastructural findings in spindle cell (desmoplastic/neurotropic) melanoma. Appl Immunohistochem Mol Morph 2003; 11: 319.
31. Egbert B, Kempson R, Sagebiel R. Desmoplastic malignant melanoma. A Clinicohistopathologic study of 25 cases. Cancer 1988; 62: 2033.
32. Smithers BM, McLeod GR, Little JH. Desmoplastic melanoma: patterns of recurrence. World J Surg 1992; 16: 186.
33. Chorny JA, Barr RJ. S100-positive spindle cells in scars: a diagnostic pitfalls in the re-excision of desmoplastic melanoma. Am J Dermatopathol 2002; 24: 309.
34. Quinn MJ, Crotty KA, Thompson JF, Coats AS, O'Brien CJ, McCarthy WH Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer 1998; 15: 1128.
35. Jaroszewsky DE, Pockaj BA, DiCaudo DJ, Bite U. The clinical behaviour of desmoplastic melanoma. Am J Surg 2001; 182: 590.
36. Gyorky DE, Busam K, Panageas K, Brady MS, Coit DG. Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma. Ann Surg Oncol 2003; 10: 403.
37. Patel P, Levin K, Waltz K, Helm KF. Myxoid melanoma: immunohistochemical studies and a review of the literature. J Am Acad Dermatol 2002; 46: 264.
38. Urso C, Giannotti B, Bondi R. Myxoid melanoma of the skin. Arch Pathol Lab Med 1990; 114: 527.
39. Lucas DR, Tazelaar HD, Unni KK, et al. Osteogenic melanoma: a rare variant of malignant melanoma. Am J Surg Pathol 1993; 17: 400.
40. Moreno A, Lamarca J, Martinez R, Guix M. Osteoid and bone formation in desmoplastic malignant melanoma. J Cutan Pathol 1986; 13: 128.
41. Banerjee SS, Coyne JD, Menasce LP, Lobo CJ, Hirsch PJ. Diagnostic lessons of mucosal melanoma with osteocartilagineous differentiation. Histopathology 1998; 33: 255.
42. Denton KJ, Stretch J, Athanasou N. Osteoclast-like giant cells in malignant melanoma. Histopathology 1998; 20: 179.
43. Peters MS, Su WPD. Balloon cell malignant melanoma. J Am Acad Dermatol 1985; 13: 35.
44. Kao GF, Helwig EB, Graham JH. Balloon cell malignant melanoma of the skin: a clinicopathologic study of 34 cases with histochemical, immunohistochemical and ultrastructural observations. Cancer 1992; 69: 2942.
45. Mowat A, Reid R, MacKie R. Balloon cell metastatic melanoma: an important differential diagnosis of clear cell tumours. Histopathology 1994; 24: 469.
46. Thelmo MC, Sagebiel RW, Treseler PA, et al. Evaluation of sentinel lymph node status in spindle cell melanomas. J Am Acad Dermatol 2001; 44: 451.
47. Skelton HG, Maceira J, Smith KJ, et al. HMB45 negative spindle cell malignant melanoma. Am J Dermatopathol 1997; 19: 580.
48. Prieto VG, Woodruff JM. Expression of basement membrane antigens in spindle cell melanoma. J Cutan Pathol 1998; 25: 297.
49. Breier F, Feldmann R, Fellenz C, et al. Primary invasive signet-ring cell melanoma. J Cutan Pathol 1999; 26: 533.
50. Rutten A, Huschka U, Requena C, Rodriguez-Peralto JL, Requena L. Primary cutaneous signet-ring cell melanoma: a clinico-pathologic and immunohistochemical study of two cases. Am J Dermatopathol 2003; 25: 418.
51. Bastian BC, Kutzner H, Yen TS, LeBoit PE. Signet-ring cell formation in cutaneous neoplasms. J Am Acad Dermatol 1999; 41: 606.
52. Won JH, Ahn SK, Lee SH, Lee WS, Kim SC. Signet-ring cell melanoma: poor prognostic factor? Br J Dermatol 1994; 131: 135.
53. House N, Fedok F, Maloney ME, Helm KF. Malignant melanoma with clinical and histological features of Merkel cell carcinoma. J Am Acad Dermatol 1994; 31: 839.
54. Hanson IM, Banerjee SS, Menasce LP, Prescott RG. A Study of eleven cutaneous malignant melanomas in adults with small-cell morphology: emphasis on diagnostic difficulties and unusual features. Histopathology 2002; 40: 496.
55. Barnhill RL, Flotte T, Fleishli M, Perez-Atayde AR. Childhood melanoma and atypical Spitz tumors. Cancer 1995; 76: 1833.
56. Spatz A, Ruiter D, Hardmeier T, et al. Malignant melanoma in childhood: an EORTC-MCG multicenter study on the clinico-pathologic aspects. Int J Cancer 1996; 68: 317.
57. Kossard S, Wilkinson B. Nucleolar organizer regions and image analysis nuclear morphometry of small cell (nevoid) melanoma. J Cutan Pathol 1995; 22: 132.
58. The malignant melanoma group. Small cell melanoma and ulceration as predictors of positive sentinel lymph node in malignant melanoma patients. Melanoma Res 2004; 14: 277.
59. Crowson AN, Magro CM, Mihm MC Jr. Malignant melanoma with prominent pigment synthesis: animal type melanoma- a clinical and histological study of 6 cases with a consideration of other melanocytic neoplasms with prominent pigment synthesis. Hum Pathol 1999; 30: 543.
60. Richardson SK, Mihm MC, Tannous ZS. Congenital and infantile melanoma; review of the literature and report of an uncommon variant, 'equine type' melanoma. J Cutan Pathol 2000; 27: 570.
61. Requena L, de la Cruz A, Moreno C, Sangueza O, Requena C. Animal-type melanoma. A report of a case with balloon-cell change and sentinel lymph node metastasis. Am J Dermatopathol 2001; 23: 341.
62. Batolo D, Lentini M. Human equine type melanoma: clinicopathologic study of 4 cases. Pathologica 2004; 96: 18.
63. Zembowicz A, Carney JA, Mihm MC. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol 2004; 28: 31.
64. Giuliano AE, Cochran AJ, Morton DL. Melanoma from unknown primary site and amelanotic melanoma. Semin Oncol 1982; 9: 442.
65. Arroyo MP, Chu DH, Mobini N, Park HS. Verrucous plaque on the foot. J Cutan Pathol 2004; 31: 271.
66. Pizzichetta MA, Talamini R, Stanganelli I. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features. Br J Dermatol 2004; 150: 117.
67. Koch SE, Lange JR. Amelanotic melanoma: the great masquerader. J Am Acad Dermatol 2000; 42: 731.
68. Okun MR. Melanoma resembling spindle and epithelioid cell nevus. Arch Dermatol 1979; 115: 1416.
69. Crotty KA, Scolyer RA, Palmer AA, Wang L, McCarthy SW. Spitz nevus versus Spitzoid melanoma: when and how can they be distinguished? Pathology 2002; 34: 6.
70. Fabrizi G, Massi G. Spitzoid melanoma in teenagers: an entity with no better prognosis than that of other forms of melanoma. Histopathology 2001; 38: 448.
71. Mihic-Probst D, Zhao J, Saremaslani P, Baer A, Komminoth P, Heitz PU. Spitzoid malignant melanoma with lymph-node metastasis. Is a copy-number loss on chromosome 6q a marker of malignancy? Virchows Arch 2001; 439: 823.
72. Riccioni L, Di Tommaso L, Collina G. Actin-rich desmoplastic malignant melanoma: report of three cases. Am J Dermatopathol 1999; 21: 537.
73. Borek BT, McKee PH, Freeman JA, Maguire B, Brander WL, Calonje E. Primary malignant melanoma with rhabdoid features: a histologic and immunohistochemical study of three cases. Am J Dermatopathol 1998; 20: 123.
74. Sexton M, Maize JC. Malignant melanoma simulating schwannian differentiation. Am J Dermatopathol 1985; 7 (Suppl.): 171.
75. Bosman C, Boldrini R, Corsi A. Malignant melanotic schwannoma or schwannian melanoma? Tumori 1995; 81: 208.
76. Grayson W, Mare LR. Ganglioneuroblastic differentiation in a primary cutaneous malignant melanoma. Am J Dermatopathol 2003; 25: 40.
77. Banerjee SS, Menasce LP, Eyden BP, Brain AN. Malignant melanoma showing ganglioneuroblastic differentiation. Am J Surg Pathol 1999; 23: 582.
78. Banerjee SS, Harris M. Morphological and immunophenotipic variations in malignant melanoma. Histopathology 2000; 36: 387.
79. King R, Busam K, Rosai J. Metastatic malignant melanoma resembling malignant peripheral nerve sheath tumor. Report of 16 cases. Am J Surg Pathol 1999; 23: 1499.
80. Diaz-Cascajo C, Hoos A. Histopathologic features of malignant peripheral nerve sheath tumor are not restricted to metastatic malignant melanoma and can be found in primary malignant melanoma also. Am J Surg Pathol 2000; 24: 1438.
81. Cruz J, Reis-Filho JS, Lopes JM. Malignant peripheral nerve sheath tumour-like primary cutaneous malignant melanoma. J Clin Pathol 2004; 57: 218.
82. Ruhoy SM, Prieto VG, Eliason SL, Grichnick JM, Burchette JL Jr, Shea CR. Malignant melanoma with paradoxical maturation. Am J Surg Pathol 2000; 24: 1600.
83. Ariyanayagam-Baksh SM, Baksh FK, Finkelstein SD, Swalsky PA, Abemethy J, Barnes EL. Malignant blue nevus: a case report and molecular analysis. Am J Dermatopathol 2003; 25: 21.
84. Granter SR, Mckee PH, Calonje E, Mihm MC Jr, Busam K. Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: a clinicopathological study of 10 cases on the spectrum of so-called 'malignant blue nevus'. Am J Surg Pathol 2001; 25: 316.
85. Aloi F, Pick A, Pippione M. Malignant cellular blue nevus; a clinicopathologic study of 6 cases. Dermatology 1996; 192: 36.
86. Pich A, Chiusa L, Margaria E, Aloi F. Proliferative activity in the malignant cellular blue nevus. Hum Pathol 1993; 24: 1323.
87. Gayraud A, Lorenzato M, Sartelet H, et al. Malignant blue nevus: clinicopathologic study with AgNOR measurement. Seven cases (in French). Ann Dermatol Venereol 2002; 129: 1359.
88. Spatz A, Zimmerman U, Bachollet B, et al. Malignant blue nevus of the vulva with late ovarian metastases. Am J Dermatopathol 1998; 20: 408.
89. Segal NH, Pavlidis P, Noble WS, et al. Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol 2003; 21: 1775.
90. Deenik W, Mooj WJ, Rutgers EJ, et al. Clear cell sarcoma (malignant melanoma) of soft parts. A clinicopathologic study of 30 cases. Cancer 1999; 86: 969.
91. Marques B, Terrier P, Voigt JJ, Mihura J, Coindre JM. Clear cell soft tissue sarcoma. Clinical, histopathological and prognostic study of 36 cases, (in french). Ann Pathol 2000; 20: 298.
92. Langezaal SM, Graadt van Roggen JF, Cleton-jansen AM, Baelde JJ, Hogendoorn PC. Malignant melanoma is genetically distinct from clear cell sarcoma or tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer 2001; 84: 535.
93. Panagopoulos I, Mertens F, Isaksson M, Mandhal N. Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses). Cancer Genet Cytogenet 2005; 156: 74.
94. Jacobs IA, Chang CK, Guzman G, Salti GI. Clear cell sarcoma: an institutional review. Am Surg 2004; 70: 300.
95. Sara AS, Evans HL, Benjamin RS. Malignant melanoma of soft parts (clear cell sarcoma). A study of 17 cases, with emphasis on prognostic factors. Cancer 1990; 15: 367.
96. Reed RJ, Ichinose H, Clark WH Jr, Mihm MC Jr. Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol 1975; 2: 119.
97. Schmoeckel C, Castro CE, Braun-Falco O. Nevoid malignant melanoma. Arch Dermatol Res 1985; 277: 362.
98. Wong TY, Suster S, Duncan LM, Mihm M Jr. Nevoid melanoma: a clinicopathological study of seven cases of malignant melanoma mimicking spindle and epithelioid cell nevus and verrucous dermal nevus. Hum Pathol 1995; 26: 171.
99. McNutt NS, Urmacher C, Hakimian Hoss DM, Lugo J. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity. J Cutan Pathol 1995; 22: 502.
100. Zembowicz A, McCusker M, Chiarelli K, et al. Morphological analysis of nevoid melanoma: a study of 20 cases with a review of the literature. Am J Dermatopathol 2001; 23: 167.
101. Philips ME, Margolis RJ, Merot Y, et al. The spectrum of minimal deviation melanoma: a clinicopathologic study of 21 cases. Hum Pathol 1986; 17: 796.